# RVL Pharmaceuticals Reports Double-Digit Revenue Growth in Q3 2026, Advancing the Mission to Build the Leading Ocular Vitality Platform

- Source: PR Newswire M&A
- Published: 2026-10-30T13:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/rvl-pharmaceuticals-reports-double-digit-revenue-growth-in-q3-2026-advancing-the-mission-to-build-the-leading-ocular-vitality-platform-302924340.html
- Canonical: https://groundlevelnews.com/story/rvl-pharmaceuticals-reports-double-digit-revenue-growth-in-q3-2026-adv-daf3d7/

BRIDGEWATER, N.J., Oct. 30, 2026 /PRNewswire/ -- RVL Pharmaceuticals Inc. and its affiliates (together, "RVL") announced strong third-quarter performance, with continued double-digit year-over-year revenue growth driven by increasing consumer demand, advancement of a new celebrity...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._